CHINA PHARMA HOLDINGS, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of -$1.47 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-11-14
- 2017-09-30: Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month -$1.47M.
- 2016-09-30: Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month -$3.80M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month |
|---|---|
| 2017-09-30 | -$1.47M 10-Q · filed 2017-11-14 |
| 2016-09-30 | -$3.80M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |